Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 09, 2026 14:17 ET | Source: TMates

TMates GLP-1 Weight Loss Program Claims Evaluated: 2026 Consumer Research Report on Compounded Semaglutide, Tirzepatide, Telehealth Weight-Loss Access, Pricing, and Verification Considerations

TMates GLP-1 claims evaluated: compounded semaglutide, tirzepatide telehealth access, pricing, provider structure, and consumer verification.